Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Rita Humeniuk, PhD
Gilead Sciences, Inc.
Poster(s):
(505) Drug-drug Interaction Profiling of Obeldesivir, A Promising Oral Treatment for COVID-19
Thursday, October 12, 2023
12:15 PM – 1:30 PM
US ET
(538) Clinical Evaluation of Drug-drug Interactions with Remdesivir
Thursday, October 12, 2023
12:15 PM – 1:30 PM
US ET
(539) Efficacy in Multiple SARS-CoV-2 Animal Models Supports Phase 3 Dose Selection for Obeldesivir
Thursday, October 12, 2023
12:15 PM – 1:30 PM
US ET
